Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04617574 · ClinicalTrials.gov registry record
Endostapler Sleeve Gastrectomy Study
A clinical trial, sponsored by Lexington Medical.
- Completed
- Registry status
- 60
- Enrollment target
NCT04617574: Completed study, sponsored by Lexington Medical.
NCT04617574 is a clinical trial that has completed, run by Lexington Medical. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04617574 has completed, sponsored by Lexington Medical.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The goal of this prospective, post-market study is to measure AEON™ Endostapler performance for laparoscopic sleeve gastrectomy surgery versus the Endo GIA™ Reloads with Tri-Staple™ Technology from Medtronic.
Primary Outcome
Intraoperative staple line bleeding score from endoscopic images as measured by the provided Bleeding Severity Scale (1 = No bleeding; 2 = Minimal bleeding; 3= Moderate bleeding; 4 = Excessive bleeding; 5 = Profuse bleeding). A lower value represents a better outcome.
Interventions
- DEVICE AEON Endostapler
- DEVICE Endo GIA Reloads with Tri-Staple Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-09-15 |
| Est. Completion | 2021-07-10 |
What the finished NCT04617574 record still lists
NCT04617574 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which AEON Endostapler is the first listed.
NCT04617574 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04617574 about?
NCT04617574 is a clinical study titled "Endostapler Sleeve Gastrectomy Study". The goal of this prospective, post-market study is to measure AEON™ Endostapler performance for laparoscopic sleeve gastrectomy surgery versus the Endo GIA™ Reloads with Tri-Staple™ Technology from Medtronic.
What is the current status of trial NCT04617574?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-09-15. Estimated completion is 2021-07-10.
What interventions are being tested in trial NCT04617574?
The interventions under investigation include: AEON Endostapler (DEVICE), Endo GIA Reloads with Tri-Staple Technology (DEVICE).
Who is sponsoring clinical trial NCT04617574?
This trial is sponsored by Lexington Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI